Company Advanced Cell Technology, Inc. OTC Bulletin Board
Equities
ACTC
US00752K1051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
John Heffernan
PRN | Corporate Officer/Principal | - | 15-02-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 51 | - | |
Masaaki Hirano
BRD | Director/Board Member | 57 | - |
Toru Yoshimitsu
BRD | Director/Board Member | 61 | - |
President | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,300,462 | 38,904,811 ( 91.97 %) | 0 | 91.97 % |
Company contact information
Astellas Institute for Regenerative Medicine
33 Locke Drive
01752, Marlborough
+508-756-1212
https://www.ocata.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- Stock
- ACTC Stock
- Company Advanced Cell Technology, Inc.